Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Iovance Biotherapeutics (IOVA) Other Gross PP&E Adjustments (2016 - 2025)

Iovance Biotherapeutics (IOVA) has disclosed Other Gross PP&E Adjustments for 10 consecutive years, with $92.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 89.23% to $92.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $92.7 million, a 89.23% increase, with the full-year FY2025 number at $92.7 million, up 89.23% from a year prior.
  • Other Gross PP&E Adjustments was $92.7 million for Q4 2025 at Iovance Biotherapeutics, down from $117.4 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $143.6 million in Q3 2024 to a low of $49.0 million in Q4 2024.
  • A 3-year average of $85.0 million and a median of $76.3 million in 2023 define the central range for Other Gross PP&E Adjustments.
  • Peak YoY movement for Other Gross PP&E Adjustments: soared 105.74% in 2024, then dropped 23.21% in 2025.
  • Iovance Biotherapeutics' Other Gross PP&E Adjustments stood at $50.8 million in 2023, then decreased by 3.6% to $49.0 million in 2024, then soared by 89.23% to $92.7 million in 2025.
  • Per Business Quant, the three most recent readings for IOVA's Other Gross PP&E Adjustments are $92.7 million (Q4 2025), $117.4 million (Q3 2025), and $102.9 million (Q2 2025).